Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I

Patricia I. Dickson, Stephen Hanson, Michael F. McEntee, Charles H. Vite, Carole A. Vogler, Anton Mlikotic, Agnes H. Chen, Katherine P. Ponder, Mark E. Haskins, Brigette L. Tippin, Steven Q. Le, Merry B. Passage, Catalina Guerra, Ashley Dierenfeld, Jackie Jens, Elizabeth Snella, Shih hsin Kan, N. Matthew Ellinwood

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Abstract

Enzyme replacement therapy (ERT) with intravenous recombinant human alpha-. l-iduronidase (IV rhIDU) is a treatment for patients with mucopolysaccharidosis I (MPS I). Spinal cord compression develops in MPS I patients due in part to dural and leptomeningeal thickening from accumulated glycosaminoglycans (GAG). We tested long-term and every 3-month intrathecal (IT) and weekly IV rhIDU in MPS I dogs age 12-15. months (Adult) and MPS I pups age 2-23. days (Early) to determine whether spinal cord compression could be reversed, stabilized, or prevented. Five treatment groups of MPS I dogs were evaluated (n= 4 per group): IT. +. IV Adult, IV Adult, IT + IV Early, 0.58. mg/kg IV Early and 1.57. mg/kg IV Early. IT + IV rhIDU (Adult and Early) led to very high iduronidase levels in cervical, thoracic, and lumber spinal meninges (3600-29,000% of normal), while IV rhIDU alone (Adult and Early) led to levels that were 8.2-176% of normal. GAG storage was significantly reduced from untreated levels in spinal meninges of IT + IV Early (p< .001), IT. +. IV Adult (p= .001), 0.58. mg/kg IV Early (p= .002) and 1.57. mg/kg IV Early (p< .001) treatment groups. Treatment of dogs shortly after birth with IT. +. IV rhIDU (IT + IV Early) led to normal to near-normal GAG levels in the meninges and histologic absence of storage vacuoles. Lysosomal storage was reduced in spinal anterior horn cells in 1.57. mg/kg IV Early and IT + IV Early animals. All dogs in IT + IV Adult and IV Adult groups had compression of their spinal cord at 12-15. months of age determined by magnetic resonance imaging and was due to protrusion of spinal disks into the canal. Cord compression developed in 3 of 4 dogs in the 0.58. mg/kg IV Early group; 2 of 3 dogs in the IT + IV Early group; and 0 of 4 dogs in the 1.57. mg/kg IV Early group by 12-18. months of age. IT + IV rhIDU was more effective than IV rhIDU alone for treatment of meningeal storage, and it prevented meningeal GAG accumulation when begun early. High-dose IV rhIDU from birth (1.57. mg/kg weekly) appeared to prevent cord compression due to protrusion of spinal disks.

Original languageEnglish
Pages (from-to)115-122
Number of pages8
JournalMolecular genetics and metabolism
Volume101
Issue number2-3
DOIs
StatePublished - Oct 2010

Keywords

  • Enzyme replacement therapy
  • Hurler
  • Intrathecal
  • Lysosomal storage disease
  • Mucopolysaccharidosis
  • Spinal cord compression

Fingerprint

Dive into the research topics of 'Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I'. Together they form a unique fingerprint.

Cite this